Patients with suspected clear cell renal cell carcinoma (ccRCC) research hub

A Phase I study to evaluate the safety and dosimetry of 68Ga-OncoCAIX in patients with CAIX-positive cancer

This early-stage study is testing a new scan called 68Ga-OncoCAIX in people with a type of kidney cancer called clear cell renal cell carcinoma. Its main goal is to see if the scan is safe and how much of the medicine in the scan reaches the cancer cells.